Primary Immunodeficiency Patient Recruitment in Delaware

TheraNovex connects clinical trial sponsors with pre-screened, eligible Primary Immunodeficiency patients across Delaware, including Wilmington, Dover, Newark, and beyond.

Primary immunodeficiency patient recruitment for IVIG, gene therapy, and HSCT clinical trials.

Who qualifies: Patients with confirmed PID including CVID, XLA, SCID, and other antibody deficiencies.

Recruitment challenges: Immunoglobulin level and lymphocyte subset requirements.

Our approach: Allergy/immunology and hematology referral networks with immunoglobulin pre-screening.

Our recruitment network spans all major metropolitan areas in Delaware, ensuring broad geographic coverage for your Primary Immunodeficiency trial.